Moderna gets full US approval for COVID shot in at-risk children 6 months and older
Coronavirus,Coronavirus Vaccine,Vaccines,FDA
From the Center
AllSides Media Bias Rating: Center
The U.S. Food and Drug Administration has granted full approval for Moderna's (MRNA.O), opens new tab COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
Scotland, Wales, Northern Ireland Leaders to Meet to Begin Dissolution of UK - The Telegraph
September 13th, 2026
Headline Roundup
CDC Declares End to Cyclospora Outbreak Despite Ongoing Investigations
September 11th, 2026
News
What the Media Missed: Children Recovered, Heat Deaths Soared, and More
Malayna J. Bizier
September 12th, 2026
